fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 20 Sep 2026

TITAN, full dossier

Titan Company is seeing a sharp divergence in demand across India’s watch market, with the sub- ₹1,000 segment facing serious sluggishness even as consumers increasingly opt for premium and higher-priced watches.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Titan Company is seeing a sharp divergence in demand across India’s watch market, with the sub- ₹1,000 segment facing serious sluggishness even as consumers increasingly opt for premium and higher-priced watches.

livemint.com20 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Titan Company

₹4,515.70

▼ -1.55%

Close (EOD), as of 1 Oct 2026 · source

Titan Company: results, dividends, orders, the full cited record →

More on Titan Company

So far in Q2FY27, Titan shares are up 6%.

30 Sep 2026 · 1 publisher

NSE shares debuted at ₹1,800 on September 24, rising to an intraday high of ₹1,878, and with a market capitalization of ₹4.63 lakh crore, NSE became the ninth-largest listed company in India.

25 Sep 2026 · 1 publisher

Titan Company is open to acquiring or investing in smaller and emerging watch brands as part of its growth strategy.

22 Sep 2026 · 1 publisher

Titan Company is exploring acquisitions and investments in emerging watch brands and anticipates a strong festive season driven by healthy consumer demand.

22 Sep 2026 · 1 publisher

Titan is open to acquiring watch companies to strengthen its premium and luxury watch portfolio.

21 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.